Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan

Stem Cells

Volumn 15, Issue 4, 1997, Pages 314-323

  Basch, Ross S ^a,b   Quito, Francis L ^a   Beh, Jane ^a   Hirst, John A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow; Hematopoiesis; SCID Mice; Transplantation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; DRUG EFFECT; ERYTHROCYTE; GROWTH REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NONHUMAN;

ANIMALIA;

EID: 0030850175     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150314     Document Type: Article

References (41)

1. Steele AA, Sensenbrenner LL, Young MG. Growth and differentiation of normal and leukemic human bone marrow cells cultured in diffusion chambers. Exp Hematol 1977;5:199-210.
2. Mosier DE, Gulizia RJ, Baird SM et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-259.
3. Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988;242:1706-1709.
4. Namikawa R, Kaneshima H, Lieberman M et al. Infection of the SCID-hu mouse by HIV-1. Science 1988;242:1684-1686.
5. Namikawa R, Weilbaecher KN, Kaneshima H et al. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 1990;172:1055-1063.
6. Lapidot T, Pflumio F, Doedens M et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992;255:1137-1141.
7. Barry TS, Jones DM, Richter CB et al. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 1991;173:167-180.
8. McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
9. Goan SR, Fichtner I, Just U et al. The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood 1995;86:89-100.
10. Aldrovandi GM, Feurer G, Gao L et al. The SCID-hu mouse as a model for HIV-1 infection. Nature 1993;363:732-736.
11. Wagner JE, Collins D, Fuller S et al. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 1995;86:512-523.
12. Vormoor J, Lapidot T, Pflumio F et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83:2489-2497.
13. Kollmann TR, Kim A, Zhuang X et al. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proc Natl Acad Sci USA 1994;91:8032-8036.
14. Hardy RR, Shinton SA, Hayakawa K. Repopulation of SCID mice with fetal-derived B-lineage cells. Curr Top Microbiol Immunol 1992; 182:73-80.
15. Barry TS, Haynes BF. In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice. J Clin Immunol 1992;12:311-324.
16. Vandekerckhove BA, Krowka JF, McCune JM et al. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol 1991;146:4173-4179.
17. Vandekerckhove BA, Jones D, Punnonen J et al. Human Ig production and isotype switching in severe combined immunodeficient-human mice. J Immunol 1993;151:128-137.
18. Botnick LE, Hannon EC, Vigneulle R et al. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 1981;41:2338-2342.
19. Fried W, Kedo W, Barone J. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res 1977;37:1205-1209.
20. Xavier D, Charbord P, Neel H et al. Human granulocyte colony growth: differences between serum-free and serum-dependent cultures. Exp Hematol 1985;13:1133-1137.
21. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-530.
22. - progenitor cells in long-term cultures and semisolid assays. Blood 1993;81:2916-2924.
23. Kobari L, Dubart A, Le Pesteur F et al. Hematopoietic-promoting activity of the murine stromal cell line MS-5 is not related to the expression of the major hematopoietic cytokines. J Cell Physiol 1995;163:295-304.
24. Bandini G, Belardinelli A, Rosti G et al. Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies. Bone Marrow Transplant 1994;13:577-581.
25. Biggs JC, Szer J, Crilley P et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 1992;80:1352-1357.
26. Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol 1991;9:323-350.
27. Kirchgessner CU, Patil CK, Evans JW et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 1995;267:1178-1183.
28. Hirsch E, Iglesias A, Potocnik AJ et al. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta 1 integrins. Nature 1996;380:171-175.
29. Hatzfeld J, Batard P, Cardoso AA et al. Purification and release from quiescence of umbilical cord blood early progenitors reveal their potential to engraft adults. Blood Cells 1994;20:430-434.
30. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993;90:8707-8711.
31. Kovach NL, Lin N, Yednock T et al. Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 1995;85:159-167.
32. Turner ML, McIlwaine K, Anthony RS et al. Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood. STEM CELLS 1995;13:311-316.
33. Yonemura Y, Ku H, Hirayama F et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996;93:4040-4044.
34. Kaufman CL, Colson YL, Wren SM et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994;84:2436-2446.
35. Weiss L, Geduldig U. Barrier cells: stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood 1991;78:975-990.
36. Hoffmann Fezer G, Kranz B, Gall C et al. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors. Eur J Immunol 1992;22:3161-3166.
37. McCune JM. Epstein-Barr associated lymphoproliferative disease in mice and men. Lab Invest 1991;65:377-380.
38. Cannon MJ, Pisa P, Fox RI et al. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 1990;85:1333-1337.
39. Traycoff CM, Abboud MR, Laver J et al. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone narrow counterparts? Blood Cells 1994;20:382-391.
40. Carow CE, Hangoc G, Broxmeyer HE. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 1993;81:942-949.
41. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-791.